SA PRO
Free Account
Agilon Health, Inc.AGLNYSE
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
23 analysts·High coverage
26%
Rating Distribution
Strong Buy
00%
Buy
626%
Hold
1565%
Sell
29%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Oct 7, 2025Wells Fargo
Agilon Health price target lowered to $1.50 from $5 at Wells Fargo
Target:$1.50
+33.9%from $1.12
Aug 15, 2025Jefferies
Agilon Health price target lowered to $1.10 from $2.40 at Jefferies
Target:$1.10
+0.5%from $1.09
Oct 29, 2024Citigroup
Citi Downgrades agilon health Inc (AGL) to Sell
Target:$2.50
-0.8%from $2.52
Oct 2, 2024Bank of America Securities
Agilon Health downgraded to Underperform from Buy at BofA
Target:$3.00
-15.1%from $3.54
Aug 8, 2024Deutsche Bank
agilon health Inc (AGL) PT Lowered to $4 at Deutsche Bank
Target:$4.00
-28.6%from $5.60
May 29, 2024Robert W. Baird
Agilon Health initiated with a Neutral at Baird
Target:$6.00
+4.2%from $5.76
May 24, 2024Truist Financial
agilon health Inc (AGL) PT Raised to $6.50 at Truist Securities
Target:$6.50
+15.0%from $5.65
Jul 26, 2022Truist Financial
Agilon Health (AGL) Stock: $33 Target And Buy Rating
Target:$33.00
+31.3%from $25.13

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance